BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 37172427)

  • 1. FATP2 regulates non-small cell lung cancer by mediating lipid metabolism through ACSL1.
    Chen Y; Zhao Y; Deng Y; Yang Y; Xu L; Fu J
    Tissue Cell; 2023 Jun; 82():102105. PubMed ID: 37172427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACSL1-Mediated Fatty Acid β-Oxidation Enhances Metastasis and Proliferation in Endometrial Cancer.
    Zhou Y; Li Y; Chen G; Guo X; Gao X; Meng J; Xu Y; Zhou N; Zhang B; Zhou X
    Front Biosci (Landmark Ed); 2024 Feb; 29(2):66. PubMed ID: 38420815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibition of Nrf2 accelerates renal lipid deposition through suppressing the ACSL1 expression in obesity-related nephropathy.
    Chen Y; He L; Yang Y; Chen Y; Song Y; Lu X; Liang Y
    Ren Fail; 2019 Nov; 41(1):821-831. PubMed ID: 31488013
    [No Abstract]   [Full Text] [Related]  

  • 4. MiR-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-CoA synthetase long-chain family member 1 (ACSL1) mRNA.
    Cui M; Wang Y; Sun B; Xiao Z; Ye L; Zhang X
    Biochem Biophys Res Commun; 2014 Feb; 444(2):270-5. PubMed ID: 24462768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of CD36 and acyl-CoA synthetases FATP2, FATP4 and ACSL1 increases fatty acid uptake in human hepatoma cells.
    Krammer J; Digel M; Ehehalt F; Stremmel W; Füllekrug J; Ehehalt R
    Int J Med Sci; 2011; 8(7):599-614. PubMed ID: 22022213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of ROS in myeloid-derived suppressor cells through targeting fatty acid transport protein 2 enhanced anti-PD-L1 tumor immunotherapy.
    Adeshakin AO; Liu W; Adeshakin FO; Afolabi LO; Zhang M; Zhang G; Wang L; Li Z; Lin L; Cao Q; Yan D; Wan X
    Cell Immunol; 2021 Apr; 362():104286. PubMed ID: 33524739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FATP2-targeted therapies - A role beyond fatty liver disease.
    Qiu P; Wang H; Zhang M; Zhang M; Peng R; Zhao Q; Liu J
    Pharmacol Res; 2020 Nov; 161():105228. PubMed ID: 33027714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of FATP2-mediated tubular lipid metabolic reprogramming in renal fibrogenesis.
    Chen Y; Yan Q; Lv M; Song K; Dai Y; Huang Y; Zhang L; Zhang C; Gao H
    Cell Death Dis; 2020 Nov; 11(11):994. PubMed ID: 33219209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of human fatty acid transport protein 2/very long chain acyl-CoA synthetase 1 (FATP2/Acsvl1) reveals distinct patterns of trafficking of exogenous fatty acids.
    Melton EM; Cerny RL; DiRusso CC; Black PN
    Biochem Biophys Res Commun; 2013 Nov; 440(4):743-8. PubMed ID: 24113382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preservation of Acyl Coenzyme A Attenuates Pathological and Metabolic Cardiac Remodeling Through Selective Lipid Trafficking.
    Goldenberg JR; Carley AN; Ji R; Zhang X; Fasano M; Schulze PC; Lewandowski ED
    Circulation; 2019 Jun; 139(24):2765-2777. PubMed ID: 30909726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic Analysis of Gene Expression Alterations and Clinical Outcomes for Long-Chain Acyl-Coenzyme A Synthetase Family in Cancer.
    Chen WC; Wang CY; Hung YH; Weng TY; Yen MC; Lai MD
    PLoS One; 2016; 11(5):e0155660. PubMed ID: 27171439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACSL1 affects Triglyceride Levels through the PPARγ Pathway.
    Li T; Li X; Meng H; Chen L; Meng F
    Int J Med Sci; 2020; 17(6):720-727. PubMed ID: 32218693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of acyl-CoA synthetase-1 increases lipid deposition in hepatic (HepG2) cells and rodent liver in vivo.
    Parkes HA; Preston E; Wilks D; Ballesteros M; Carpenter L; Wood L; Kraegen EW; Furler SM; Cooney GJ
    Am J Physiol Endocrinol Metab; 2006 Oct; 291(4):E737-44. PubMed ID: 16705061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin suppresses the abnormal lipid metabolism in liver cancer cells via disrupting an NFκB-ACSL1 signaling.
    Yang G; Wang Y; Feng J; Liu Y; Wang T; Zhao M; Ye L; Zhang X
    Biochem Biophys Res Commun; 2017 May; 486(3):827-832. PubMed ID: 28359761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic enzyme ACSL3 is a prognostic biomarker and correlates with anticancer effectiveness of statins in non-small cell lung cancer.
    Fernández LP; Merino M; Colmenarejo G; Moreno-Rubio J; Sánchez-Martínez R; Quijada-Freire A; Gómez de Cedrón M; Reglero G; Casado E; Sereno M; Ramírez de Molina A
    Mol Oncol; 2020 Dec; 14(12):3135-3152. PubMed ID: 33030783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acyl CoA synthetase-1 links facilitated long chain fatty acid uptake to intracellular metabolic trafficking differently in hearts of male versus female mice.
    Goldenberg JR; Wang X; Lewandowski ED
    J Mol Cell Cardiol; 2016 May; 94():1-9. PubMed ID: 26995156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficiency of cardiac Acyl-CoA synthetase-1 induces diastolic dysfunction, but pathologic hypertrophy is reversed by rapamycin.
    Paul DS; Grevengoed TJ; Pascual F; Ellis JM; Willis MS; Coleman RA
    Biochim Biophys Acta; 2014 Jun; 1841(6):880-7. PubMed ID: 24631848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial acyl-CoA synthetase 1 is not required for inflammatory and apoptotic effects of a saturated fatty acid-rich environment.
    Li X; Gonzalez O; Shen X; Barnhart S; Kramer F; Kanter JE; Vivekanandan-Giri A; Tsuchiya K; Handa P; Pennathur S; Kim F; Coleman RA; Schaffer JE; Bornfeldt KE
    Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):232-40. PubMed ID: 23241406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FATP2 is a hepatic fatty acid transporter and peroxisomal very long-chain acyl-CoA synthetase.
    Falcon A; Doege H; Fluitt A; Tsang B; Watson N; Kay MA; Stahl A
    Am J Physiol Endocrinol Metab; 2010 Sep; 299(3):E384-93. PubMed ID: 20530735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2.
    Alicea GM; Rebecca VW; Goldman AR; Fane ME; Douglass SM; Behera R; Webster MR; Kugel CH; Ecker BL; Caino MC; Kossenkov AV; Tang HY; Frederick DT; Flaherty KT; Xu X; Liu Q; Gabrilovich DI; Herlyn M; Blair IA; Schug ZT; Speicher DW; Weeraratna AT
    Cancer Discov; 2020 Sep; 10(9):1282-1295. PubMed ID: 32499221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.